How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,595 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Calcified retained intrauterine device in the setting of a vesicovaginal fistula (PubMed)

Calcified retained intrauterine device in the setting of a vesicovaginal fistula 29552499 2019 02 26 2214-4420 17 2018 Mar Urology case reports Urol Case Rep Calcified retained intrauterine device in the setting of a vesicovaginal fistula. 106-108 10.1016/j.eucr.2018.01.023 Scambia Jillian R JR Division of Urology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA. Lombardo Lindsay L Division of Urology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA. Division (...) Reports 2018 01 31 United States Urol Case Rep 101626357 2214-4420 Intrauterine device Transabdominal fistula repair Vaginal foreign bodies Vesicovaginal fistula 2018 01 10 2018 01 21 2018 3 20 6 0 2018 3 20 6 0 2018 3 20 6 1 epublish 29552499 10.1016/j.eucr.2018.01.023 S2214-4420(18)30011-1 PMC5850877 Obstet Gynecol. 2010 Nov;116(5):1079-87 20966692 Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):88-95 24725693 Int Urogynecol J. 2014 Dec;25(12):1699-706 25062654

Full Text available with Trip Pro

2018 Urology case reports

62. Use and discontinuation of intrauterine contraceptive device in the Greater Accra Region of Ghana (PubMed)

Use and discontinuation of intrauterine contraceptive device in the Greater Accra Region of Ghana The intrauterine contraceptive device is one of the modern long-acting and reversible contraception that is very safe and effective. Yet, less than 2 % of women are using intrauterine devices in Ghana. This study therefore explored the experiences and barriers to intrauterine contraceptive device use and discontinuation in Greater Accra Region, Ghana.Intrauterine contraceptive device users (...) was created and a series of categories for the main themes that emerged from the transcripts were developed. The transcribed data was organized, coded and manually thematically analysed in word. Study results were presented in tables and quotes from respondents.Results showed that key motivations for intrauterine contraceptive device use include effectiveness, benefits, and efficacy of the device, fertility regulation, peace of mind, contraceptive method switching, health provider effects, desire for long

Full Text available with Trip Pro

2018 Contraception and Reproductive Medicine

63. Hydronephrosis due to a Migrated Intrauterine Device into the Ureter: A Very Rare Case (PubMed)

Hydronephrosis due to a Migrated Intrauterine Device into the Ureter: A Very Rare Case Intrauterine device (IUD) insertion is a long-acting and one of the most effective modes of reversible contraception. Complications that most commonly arise following IUD insertion are failed insertion, pain, vasovagal reactions, infection, menstrual abnormalities, and expulsion. In this paper, we present the case of a woman who experienced hydronephrosis due to the migration of IUD into the ureter after 30

Full Text available with Trip Pro

2018 The Eurasian journal of medicine

64. Hysteroscopic-guided Removal of Retained Intrauterine Device: Experience at an Academic Tertiary Hospital (PubMed)

Hysteroscopic-guided Removal of Retained Intrauterine Device: Experience at an Academic Tertiary Hospital Removal of an intrauterine device can be easily done when the string is visible during speculum exam. The task becomes challenging when the string is no longer visible.The in-patient and out-patient medical records of all patients admitted for hysteroscopic-guided intrauterine device removal from January 2013 to December 2015 from a tertiary academic government hospital were retrieved

Full Text available with Trip Pro

2018 Gynecology and Minimally Invasive Therapy

65. Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal

Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03600064 Recruitment Status : Recruiting First Posted : July 25, 2018 Last Update Posted : July 25

2018 Clinical Trials

66. Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method

Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method (KIDDS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier

2018 Clinical Trials

67. Surveillance Study of the Contraceptive Intrauterine Device UT380®

Surveillance Study of the Contraceptive Intrauterine Device UT380® Surveillance Study of the Contraceptive Intrauterine Device UT380® - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Surveillance Study (...) of the Contraceptive Intrauterine Device UT380® (CCDDIUUT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03642171 Recruitment Status : Recruiting First Posted : August 22, 2018 Last Update Posted : September 3, 2018 See Sponsor

2018 Clinical Trials

68. Immediate Postpartum Insertion of Contraceptive Intrauterine Devices

Immediate Postpartum Insertion of Contraceptive Intrauterine Devices Immediate Postpartum Insertion of Contraceptive Intrauterine Devices - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Immediate Postpartum (...) Insertion of Contraceptive Intrauterine Devices The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03657602 Recruitment Status : Not yet recruiting First Posted : September 5, 2018 Last Update Posted : January 25, 2019 See

2018 Clinical Trials

69. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.

Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03686085

2018 Clinical Trials

70. The role of the Mirena Intrauterine Device(LNG-IUD) in the management of endometrial polyps - a Pilot Study. (PubMed)

The role of the Mirena Intrauterine Device(LNG-IUD) in the management of endometrial polyps - a Pilot Study. To study the hypothesis that the levonorgestrel intrauterine device (LNG-IUD) can have a role in the treatment of endometrial polyps confirmed at outpatient hysteroscopy in premenopausal women.Canadian Task Force classification level II1 (a controlled trial that is not randomised).Outpatient hysteroscopy.Premenopausal women who had a polyp diagnosed at outpatient

2018 Journal of minimally invasive gynecology

71. Use of a novel suction cervical retractor for intrauterine device insertion: a pilot feasibility trial. (PubMed)

Use of a novel suction cervical retractor for intrauterine device insertion: a pilot feasibility trial. The Bioceptive suction cervical retractor (SCR) is a novel device that can replace the standard single-tooth tenaculum to place traction on the cervix. A feasibility trial was conducted on the device for intrauterine device (IUD) placement.Our three-stage feasibility process began with Stage 1, where the device was tested on in-vitro and ex-vivo samples. In Stage 2, 10 women received (...) their IUD using the device. In Stage 3, a feasibility trial, we randomly assigned 25 consenting women to receive their IUD using either the Bioceptive SCR or the standard single-tooth tenaculum. In Stages 2 and 3, we collected pain scores using an electronically adapted 100-point visual analogue scale (VAS) at eight timepoints during and after the insertion procedure, as well as satisfaction and acceptability measures. The primary outcome was the pain score after attaching the SCR or tenaculum (VAS 3

2018 BMJ Sexual & Reproductive Health

72. Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration. (PubMed)

Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration. Studies have shown that immediate postpartum initiation of long-acting reversible contraception (LARC) methods leads to increased utilization of LARC and prevention of unintended pregnancies. It is unclear if immediate postpartum levonorgestrel-releasing intrauterine device (LNG-IUD) insertion has an effect on breastfeeding success.This study was a secondary analysis (...) of a randomized trial that compared intrauterine device (IUD) use at 6 months postpartum among women who underwent intracesarean IUD placement with women who planned for interval IUD placement at 6 or more weeks postpartum. This parallel, 1:1, nonblinded randomized trial was conducted between March 2012 and June 2014 at the University of North Carolina Women's Hospital. We recruited pregnant women aged 18-45 years who were undergoing a cesarean delivery and desired an IUD for contraception postpartum.We

2018 Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine

73. Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted After Childbirth

Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted After Childbirth Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted (...) After Childbirth and in Relation to Different Types of Coils. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control

2018 Clinical Trials

74. Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices (PubMed)

Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices Candida parapsilosis is one of the main species that is able to adhere to forming biofilms on inert materials. Adhesion is the first step towards the colonization and invasion of host cells during the infectious process. Among the infections, vulvovaginal candidiasis is increasingly common. The objective was to evaluate the profile of adherence and biofilm formation of eight (...) isolates of C. parapsilosis on the metal used in intrauterine devices (IUDs).Eight strains of C. parapsilosis presenting strong adhesion and biofilm formation properties were isolated from vaginal secretions in a previous study. To assay the adhesion and biofilm formation, copper fragments were made and cultivated in tubes containing 3 mL of phosphate-buffered saline and incubated for 6 and 24 h at 37 °C to evaluate biofilm formation. After incubation, the intensity of adherence and of biofilm

Full Text available with Trip Pro

2018 Revista do Instituto de Medicina Tropical de São Paulo

75. Studies of acute and subchronic systemic toxicity associated with a copper/low-density polyethylene nanocomposite intrauterine device (PubMed)

Studies of acute and subchronic systemic toxicity associated with a copper/low-density polyethylene nanocomposite intrauterine device The physiologic safety of devices and materials intended for clinical implantation should be evaluated. This study, a logical extension of our previous work, aimed to investigate the safety of a novel contraceptive device, the copper/low-density polyethylene nanocomposite intrauterine device (nano-Cu/LDPE IUD), through studies of its potential toxicity after

Full Text available with Trip Pro

2018 International journal of nanomedicine

76. Effect of Baseline Menstrual Bleeding Pattern on Copper Intrauterine Device Continuation. (PubMed)

Effect of Baseline Menstrual Bleeding Pattern on Copper Intrauterine Device Continuation. Heavy menstrual bleeding is a leading cause of copper intrauterine device discontinuation. Thus, girls and women with heavy baseline menstrual bleeding may be at increased risk for early copper intrauterine device discontinuation.Our objective was to assess if there was an association between baseline menstrual bleeding pattern prior to intrauterine device insertion and discontinuation rate at 12 months (...) among study participants who chose copper intrauterine device at baseline.We performed a secondary analysis of the Contraceptive CHOICE Project, a prospective observational cohort study of 9256 girls and women offered no-cost contraception for 2-3 years. Included in our study were participants who chose copper intrauterine device for contraception and for whom method continuation data at 12 months were available. Prior to contraception initiation, participants were asked to qualify their menstrual

2018 American Journal of Obstetrics and Gynecology

77. Association of Anticipated Insertional Pain With Intrauterine Device Initiation. (PubMed)

Association of Anticipated Insertional Pain With Intrauterine Device Initiation. Many providers cite pain as a barrier to intrauterine device (IUD) initiation. Our objective was to determine if young women who initiate other contraceptive methods anticipate more pain with IUD insertion than those who initiate IUDs.In this prospective cohort study, we enrolled women ages 14-24 initiating contraception at a family planning clinic. Participants rated expected pain with IUD insertion on a 0-10

2018 The Journal of Adolescent Health

78. Postpartum intrauterine devices: Clinical and programmatic review. (PubMed)

Postpartum intrauterine devices: Clinical and programmatic review. The immediate postpartum period is a critical moment for contraceptive access and an opportunity to initiate long-acting reversible contraception, which includes the insertion of an intrauterine device. The use of the intrauterine device in the postpartum period is a safe practice with few contraindications and many benefits. Although an intrauterine device placed during the postpartum period is more likely to expel compared (...) with one placed at the postpartum visit, women who initiate intrauterine devices at the time of delivery are also more likely to continue to use an intrauterine device compared with women who plan to follow up for an interval intrauterine device insertion. This review will focus on the most recent clinical and programmatic updates on postpartum intrauterine device practice. We discuss postpartum intrauterine device expulsion and continuation, eligibility criteria and contraindications, safety

2018 American Journal of Obstetrics and Gynecology

79. The Management of a Patient with a fragmented intrauterine device embedded within the Cervical Canal. (PubMed)

The Management of a Patient with a fragmented intrauterine device embedded within the Cervical Canal. A 28-year-old woman presented with a malpositioned intrauterine device (IUD) that was fragmented and significantly entrenched within the cervical canal and myometrium. IUD malposition with concomitant device fragmentation and embedded segments, albeit rare, should be a consideration given the device's prevalence.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

80. Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study (PubMed)

Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study This pilot study assessed the feasibility of conducting a larger randomized controlled trial comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG IUD) at six months postpartum when it is inserted immediately after vaginal delivery (within 10 minutes after placental expulsion) compared to insertion four to six weeks postpartum

Full Text available with Trip Pro

2018 Hawai'i Journal of Medicine & Public Health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>